Masanori Minagawa

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients

Itsuro Endo, Seiji Fukumoto, Keiichi Ozono et al. · Bone · 2008 · 206 citations

Medicine, Endocrinology, Nephrology +10

Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment

Itsuro Endo, Seiji Fukumoto, Keiichi Ozono et al. · Endocrine Journal · 2015 · 166 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16

Assessment criteria for vitamin D deficiency/insufficiency in Japan: proposal by an expert panel supported by the Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society [Opinion]

Ryo Okazaki, Keiichi Ozono, Seiji Fukumoto et al. · Journal of Bone and Mineral Metabolism · 2016 · 113 citations

Medicine, Endocrinology, Nutritional Sciences +17

Pathogenesis and diagnostic criteria for rickets and osteomalacia—proposal by an expert panel supported by the Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research, and the Japan Endocrine Society

Seiji Fukumoto, Keiichi Ozono, Toshimi Michigami et al. · Journal of Bone and Mineral Metabolism · 2015 · 81 citations

Medicine, Endocrinology, Nutrition +17

Clinical practice guidelines for congenital hyperinsulinism

Tohru Yorifuji, Reiko Horikawa, Tomonobu Hasegawa et al. · Clinical Pediatric Endocrinology · 2017 · 79 citations · Full text

Medicine, Endocrinology, Pediatrics +14